Bausch & Lomb BLCO
NYSE BLCO
$17.24 +0.04 (+0.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch & Lomb (BLCO) Liabilities and Shareholders Equity (2021 - 2026)

Bausch & Lomb's (BLCO) quarterly Liabilities and Shareholders Equity came in at $13.9 billion in Q2 2026, little changed YoY from $13.8 billion in Q2 2025, and up 0.57% on a QoQ basis from $13.8 billion in Q1 2026.

Bausch & Lomb (BLCO) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $13.9 billion in Q2 2026.

  • Quarterly Liabilities and Shareholders Equity changed 0.2% year-over-year to $13.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $55.5 billion (up 2.3% YoY) and the FY2025 annual result came in at $14.0 billion, up 4.11% from the prior year.
  • Liabilities and Shareholders Equity climbed to $13.9 billion in Q2 2026, from $13.8 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $14.0 billion in Q4 2025 to a low of $10.7 billion in Q3 2022.
  • A 5-year average of $12.7 billion and a median of $13.4 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity rose 22.18% — and 2026, when it gained 0.2%.
  • Tracing BLCO's Liabilities and Shareholders Equity over 5 years: stood at $11.1 billion in 2022, then advanced by 20.62% to $13.4 billion in 2023, then gained by 0.2% to $13.5 billion in 2024, then increased by 4.11% to $14.0 billion in 2025, then fell by 1.16% to $13.9 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $13.9 billion (Q2 2026), $13.8 billion (Q1 2026), and $14.0 billion (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 20.88 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 50.73 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 31.10 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 8.97 Bn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 39.35 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 4.08 Bn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 14.24 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 12.48 Bn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 19.79 Bn
10 Bausch & Lomb 6.14 Bn 5.76 Bn 867.00 Mn 13.86 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 13.86 Bn
Mar 31, 2026 13.78 Bn
Dec 31, 2025 14.02 Bn
Sep 30, 2025 13.83 Bn
Jun 30, 2025 13.83 Bn
Mar 31, 2025 13.43 Bn
Dec 31, 2024 13.47 Bn
Sep 30, 2024 13.52 Bn
Jun 30, 2024 13.25 Bn
Mar 31, 2024 13.29 Bn
Dec 31, 2023 13.44 Bn
Sep 30, 2023 13.07 Bn
Jun 30, 2023 11.32 Bn
Mar 31, 2023 11.17 Bn
Dec 31, 2022 11.14 Bn
Sep 30, 2022 10.70 Bn
Jun 30, 2022 11.00 Bn
Mar 31, 2022 10.91 Bn
Dec 31, 2021 10.82 Bn